Drug and Medical Device Safety: Leveraging Customs for Product Safety (Podcast 4 of 4)

The Global Pharmaceutical Center presents a series of four podcasts that delve deep into issues from Progressions 2007, The Ernst & Young Global Pharmaceutical Report. By registering for this series, you'll have access to each podcast as it is released.

Podcast 4 - Leveraging Customs for Patient Safety

Building a strong relationship with Customs authorities is indispensable in helping manufacturers and other intellectual property owners improve their supply chain performance and act effectively against counterfeit products at an operational level. Companies seeking to broaden their options for combating counterfeits should explore regional and country-specific security programs. These programs will help strengthen a company´s brand protection framework, potentially intercept harmful counterfeits, and provide long term benefits that ensure continued international supply chain efficiency.

Podcast 1 - Product Safety Compliance
Podcast 2 - Data Analytics
Podcast 3 - Product Liability

Each podcast is hosted by Chris Gray, Managing Editor of Progressions 2007, and features candid interviews with industry professionals who share their insight and opinions with listeners.

More in Biotechnology & Pharmaceutical


Released on:
Monday, October 15, 2007

n/a your local time)

Duration: 16 minutes

Note: the webcast technology is not compatible with the browser you are using. Use Internet Explorer or Firefox.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.